Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ENSC

Overview Financials Analysis Smart Money

Ensysce Biosciences, Inc.

ENSC · NASDAQ

Analyze with AI

Filings1

Total reported value$118.0

Manager	Shares	Value	Change
Covington Capital Management	100	$118.0	0.0%

SymbolENSC

Market Cap$2.8M

IPO Date2018-03-14

CEOD. Lynn Kirkpatrick

Employees7

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Intelligent Bio Solutions Inc.

INBS

$5.27

+858.18%

Vision Marine Technologies Inc.

VMAR

$1.02

+168.01%

SRx Health Solutions Inc.

SRXH

$0.5274

+73.20%

Cementos Pacasmayo S.A.A.

CPAC

$10.51

+50.36%

B. Riley Financial, Inc.

RILY

$5.36

+44.07%

Peers

Soligenix, Inc.

SNGX · NASDAQ

$1.53

-1.50%

Titan Pharmaceuticals, Inc.

TTNP · NASDAQ

$2.34

-11.36%

Oragenics, Inc.

OGEN · AMEX

$0.8253

-1.34%

KALA BIO, Inc.

KALA · NASDAQ

$0.5643

-6.91%

Xenetic Biosciences, Inc.

XBIO · NASDAQ

$2.06

-11.59%

AIM ImmunoTech Inc.

AIM · AMEX

$1.38

+4.55%

VYNE Therapeutics Inc.

VYNE · NASDAQ

$0.394

+9.44%

Qualigen Therapeutics, Inc.

QLGN · NASDAQ

$3.21

+5.59%

Kazia Therapeutics Limited

KZIA · NASDAQ

$10.10

+6.20%

Can-Fite BioPharma Ltd.

CANF · AMEX

$0.2908

+9.74%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.